Barclays’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-243,747
| Closed | -$376K | – | 5838 |
|
|
2021
Q4 | $376K | Buy |
243,747
+99,988
| +70% | +$165K | ﹤0.01% | 3323 |
|
|
2021
Q3 | $226K | Buy |
143,759
+128,498
| +842% | +$252K | ﹤0.01% | 3553 |
|
|
2021
Q2 | $40K | Sell |
15,261
-2,647
| -15% | -$4.93K | ﹤0.01% | 4239 |
|
|
2021
Q1 | $27K | Buy |
+17,908
| New | +$31.1K | ﹤0.01% | 4321 |
|
|
2020
Q3 | – | Sell |
-46,390
| Closed | -$38K | – | 5760 |
|
|
2020
Q2 | $38K | Buy |
46,390
+12,650
| +37% | +$9.4K | ﹤0.01% | 5040 |
|
|
2020
Q1 | $24K | Sell |
33,740
-68,400
| -67% | -$76.2K | ﹤0.01% | 5588 |
|
|
2019
Q4 | $136K | Buy |
102,140
+51,890
| +103% | +$72.4K | ﹤0.01% | 5295 |
|
|
2019
Q3 | $71K | Sell |
50,250
-14,651
| -23% | -$29.2K | ﹤0.01% | 5724 |
|
|
2019
Q2 | $210K | Sell |
64,901
-15,682
| -19% | -$54K | ﹤0.01% | 5060 |
|
|
2019
Q1 | $302K | Buy |
80,583
+50,551
| +168% | +$161K | ﹤0.01% | 4522 |
|
|
2018
Q4 | $65K | Buy |
30,032
+591
| +2% | +$1.47K | ﹤0.01% | 5327 |
|
|
2018
Q3 | $79K | Buy |
29,441
+23,804
| +422% | +$84.1K | ﹤0.01% | 5763 |
|
|
2018
Q2 | $24K | Sell |
5,637
-7,637
| -58% | -$28.7K | ﹤0.01% | 6086 |
|
|
2018
Q1 | $48K | Buy |
13,274
+3,117
| +31% | +$11.6K | ﹤0.01% | 5938 |
|
|
2017
Q4 | $38K | Buy |
10,157
+8,674
| +585% | +$34.7K | ﹤0.01% | 5920 |
|
|
2017
Q3 | $6K | Buy |
1,483
+714
| +93% | +$2.94K | ﹤0.01% | 6378 |
|
|
2017
Q2 | $3K | Sell |
769
-12,317
| -94% | -$48K | ﹤0.01% | 6373 |
|
|
2017
Q1 | $48K | Buy |
13,086
+12,347
| +1,671% | +$43.4K | ﹤0.01% | 5364 |
|
|
2016
Q4 | $4K | Sell |
739
-14,577
| -95% | -$66K | ﹤0.01% | 6213 |
|
|
2016
Q3 | $63K | Buy |
15,316
+15,230
| +17,709% | +$62.2K | ﹤0.01% | 4845 |
|
|
2016
Q2 | $0 | Hold |
86
| – | – | ﹤0.01% | 6745 |
|
|
2016
Q1 | $0 | Hold |
86
| – | – | ﹤0.01% | 6550 |
|
|
2015
Q4 | $0 | Sell |
86
-177
| -67% | -$760 | ﹤0.01% | 6787 |
|
|
2015
Q3 | $1K | Sell |
263
-469
| -64% | -$2.96K | ﹤0.01% | 6655 |
|
|
2015
Q2 | $6K | Buy |
732
+74
| +11% | +$617 | ﹤0.01% | 6385 |
|
|
2015
Q1 | $5K | Sell |
658
-3,265
| -83% | -$27.9K | ﹤0.01% | 6615 |
|
|
2014
Q4 | $43K | Buy |
3,923
+3,789
| +2,828% | +$45.2K | ﹤0.01% | 5842 |
|
|
2014
Q3 | $2K | Sell |
134
-150
| -53% | -$1.98K | ﹤0.01% | 7437 |
|
|
2014
Q2 | $4K | Buy |
+284
| New | +$4.62K | ﹤0.01% | 7223 |
|
Barclays's CSLT Position: Q1 2022 in Review
Barclays sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 243,747 shares — an estimated $376K sold.
Barclays first reported a position in CSLT in Q2 2014 and held it in 29 quarters. The position peaked at $376K in Q4 2021. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.
- Barclays reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
- Barclays sold 243,747 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $376K.
- Barclays first reported a position in CASTLIGHT HEALTH, INC. in Q2 2014 and held it in 29 quarters.
- Barclays's CASTLIGHT HEALTH, INC. position peaked at $376K in Q4 2021.
- 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.